Eid A, Morecki S, Slavin S
Department of Surgery B, Hadassah University Hospital, Jerusalem, Israel.
Transpl Int. 1990 Oct;3(3):141-5. doi: 10.1007/BF00355460.
The mechanism of transplantation tolerance in total lymphoid irradiation (TLI)-induced semiallogeneic bone marrow chimeras without clinical evidence of graft-versus-host disease (GVHD) was investigated using the technique of surgical parabiosis. When held in parabiosis with normal BALB/c mice, BALB/c---- (BALB/c x C57BL/6)F1 (BALB----F1) chimeras survived 7-9 days, significantly (P less than 0.001) shorter than the 12-19 day survival of normal F1 hybrids kept in parabiosis with normal BALB, and in contrast to indefinite (greater than 200 days) survival of syngeneic BALB parabiotic partners. When C57 skin grafts were placed on BALB mice held in parabiosis with BALB----F1 chimeras, C57 skin grafts survived 50-60 days, in contrast to 10-14 days in normal BALB recipients (P less than 0.001). Lethal GVHD, induced in sublethally irradiated F1 recipients by 10(7) BALB spleen cells, could not be delayed or prevented by cotransfer of 10(7) to 30 x 10(7) tolerant BALB spleen cells obtained from stable BALB----F1 chimeras. GVHD reactivity of BALB spleen cells isolated from BALB----F1 chimeras tolerant of C57 could not be recovered by depletion of Lyt2 cytotoxic suppressor cells. Taken together, in the absence of suppressive capacity by suppressor cells, these data support functional clonal deletion as the primary mechanism responsible for the maintenance of unresponsiveness to host alloantigens in TLI-induced semiallogeneic chimeras, since no protection against induction of GVHD could be documented in vivo.(ABSTRACT TRUNCATED AT 250 WORDS)
运用手术联体共生技术,研究了全身淋巴照射(TLI)诱导的半同种异体骨髓嵌合体中移植耐受的机制,这些嵌合体无移植物抗宿主病(GVHD)的临床证据。当与正常BALB/c小鼠形成联体共生时,BALB/c----(BALB/c×C57BL/6)F1(BALB----F1)嵌合体存活7 - 9天,显著短于(P<0.001)与正常BALB形成联体共生的正常F1杂种12 - 19天的存活时间,且与同基因BALB联体共生伙伴的无限期(>200天)存活形成对比。当将C57皮肤移植物置于与BALB----F1嵌合体形成联体共生的BALB小鼠上时,C57皮肤移植物存活50 - 60天,而正常BALB受体中为10 - 14天(P<0.001)。用10⁷个BALB脾细胞在亚致死剂量照射的F1受体中诱导致死性GVHD,共转移从稳定的BALB----F1嵌合体获得的10⁷至30×10⁷个耐受BALB脾细胞不能延迟或预防GVHD。从耐受C57的BALB----F1嵌合体中分离的BALB脾细胞的GVHD反应性不能通过去除Lyt2细胞毒性抑制细胞而恢复。综上所述,在缺乏抑制细胞抑制能力的情况下,这些数据支持功能性克隆缺失是TLI诱导的半同种异体嵌合体中维持对宿主同种异体抗原无反应性的主要机制,因为在体内未发现对GVHD诱导的保护作用。(摘要截断于250字)